Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight

Stopped early · Phase 2

Conditions studied: Advanced Cancer

In brief

The purpose of this study is to find out if remeron, also called mirtazapine, can help you prevent weight loss while on treatment for your cancer. Remeron is currently used to treat depression and has not been approved by the Food and Drug Administration for use to treat weight loss.

Key facts

Study ID
NCT00832520
Run by
New Mexico Cancer Research Alliance
People needed
13
Starts
2008-11-01
Expected to finish
2011-06-01
Last updated by the study team
2018-04-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.